Related Experiment Video

Updated: May 10, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy

Christopher A Alvarez-Breckenridge1, Jianhua Yu, Michael A Caligiuri

  • 1Medical Scientist Training Program; The Ohio State University Medical Center; Columbus, OH USA ; Dardinger Laboratory for Neuro-Oncology and Neurosciences; Department of Neurological Surgery; The Ohio State University Medical Center; Columbus, OH USA.

Oncoimmunology
|June 5, 2013
PubMed

Insights

Natural killer cells, part of innate immunity, can limit the effectiveness of oncolytic viruses in glioblastoma treatment. This occurs through natural cytotoxicity receptors, presenting a challenge for viral cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Oncolytic viruses show promise for glioblastoma treatment but face limited clinical success.
  • Innate immunity is a significant barrier to effective viral oncolysis in glioblastoma.

Purpose of the Study:

  • To investigate the role of natural killer (NK) cells in limiting oncolytic virus efficacy in glioblastoma.
  • To explore the mechanism of NK cell-mediated inhibition of oncolytic viruses.

Main Methods:

  • Utilizing in vitro and in vivo models of glioblastoma.
  • Assessing NK cell activity and its impact on viral replication and tumor cell lysis.
  • Investigating the involvement of natural cytotoxicity receptors (NCRs) in this interaction.

Main Results:

  • Natural killer cells were found to restrict the efficacy of oncolytic viruses in glioblastoma models.
  • This limitation is mediated through the engagement of natural cytotoxicity receptors on NK cells.
  • Understanding this interaction is crucial for improving oncolytic virotherapy.

Conclusions:

  • Natural killer cells represent a key innate immune barrier to successful oncolytic virotherapy in glioblastoma.
  • Targeting NK cell-mediated inhibition via NCRs may enhance the therapeutic potential of oncolytic viruses.
Keywords:
brain tumorcancerglioblastomainnate immunityoncolytic virus

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...